A novel substitution in NS5A enhances resistance of hepatitis C virus genotype 3 to daclatasvir (vol 102, 001496, 2021)

Author(s)

Fernandes Campos, Guilherme Rodrigues ; Ward, Joseph ; Chen, Shucheng ; Bittar, Cintia ; Vilela Rodrigues, Joao Paulo ; Candolo Martinelli, Ana de Lourdes ; Souza, Fernanda Fernandes ; Leira Pereira, Leonardo Regis ; Rahal, Paula ; Harris, Mark

• Document type: Journal article
• Source: JOURNAL OF GENERAL VIROLOGY; v. 102, n. 3, p. 1-pg., 2021-01-01.
• FAPESP's process: 18/04678-5 - Analysis of Hepatitis C virus genotype 3 resistance to direct acting antivirals
• Grantee: Guilherme Rodrigues Fernandes Campos
• Support Opportunities: Scholarships abroad - Research Internship - Doctorate
• FAPESP's process: 17/22927-0 - Study of resistance mutations to the treatment with direct-acting antivirals in patients infected with Hepatitis C virus genotype 3
• Grantee: Paula Rahal
• Support Opportunities: Regular Research Grants
• FAPESP's process: 16/03807-0 - Study of resistance mutations to treatment with Directly Acting antivirals in patients infected with hepatitis C virus genotype 3
• Grantee: Guilherme Rodrigues Fernandes Campos
• Support Opportunities: Scholarships in Brazil - Doctorate